Skip to main content

Jaguar Health, Inc.

For the period ended Dec 31, 2024. Filed Mar 31, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 31, 2025

JAGX$0.44+7.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

Item No. · Page No.
PART I
Item 1.Business1
Item 1A.Risk Factors35
Item 1B.Unresolved Staff Comments69
Item 1C.Cybersecurity69
Item 2.Properties70
Item 3.Legal Proceedings70
Item 4.Mine Safety Disclosure70
PART II
Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities71
Item 6.Selected Financial Data72
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations73
Item 7A.Qualitative and Quantitative Disclosures About Market Risk87
Item 8.Financial Statements and Supplementary Data88
Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure145
Item 9A.Controls and Procedures145
Item 9B.Other Information145
Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections145
PART III
Item 10.Directors, Executive Officers and Corporate Governance146
Item 11.Executive Compensation146
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters146
Item 13.Certain Relationships and Related Transactions, and Director Independence146
Item 14.Principal Accountant Fees and Services146
PART IV
Item 15.Exhibits, Financial Statement Schedules147
SIGNATURES156

i

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.